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Human immunodeficiency virus (HIV)-associated
nephropathy (HIVAN) is an important cause of renal failure in
those of African origin. A number of other kidney diseases
occur in HIV-positive patients. We conducted a retrospective
review of renal biopsies in HIV-positive Black African patients
to determine the prevalence of both ‘classic HIVAN’ and
non-HIVAN pathologies in this group. Clinical and laboratory
data from HIV-positive patients who underwent renal biopsy
from 1st January 2003 to 31st December 2004 were collected.
Similar information on HIV-negative patients biopsied during
the same period was also recorded by way of comparison to
try and assess the influence of the virus on renal histologic
patterns. HIV-positive group – 99 biopsies were suitable for
study. The main histologic categories were ‘classic HIVAN’
(27%) and HIV immune complex kidney disease (‘HIVICK’)
(21%). The subepithelial immune deposits in ‘HIVICK’ induced
a newly described ‘ball-in-cup’ basement membrane reaction.
Other glomerulonephritides included membranous,
post-infectious disease, mesangial hyperplasia, and
immunoglobulin A nephropathy. Overlapping clinical
presentations prevented pre-biopsy histologic predictions.
HIV-negative group – There were no examples of collapsing
focal segmental glomerulosclerosis or nonspecific immune
complex disease, but increased numbers of minimal change
and membranoproliferative disease. ‘Classic HIVAN’
accounted for less than a third of the nephropathies
occurring in HIV-positive Black South Africans. ‘HIVICK’ is
another important cause of chronic kidney disease in this
group. Future research is needed into the earlier detection
and treatment of these diseases, which have a high mortality
in our context.
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Since its first description over 20 years ago,1,2 human immu-
nodeficiency virus (HIV)-associated nephropathy (HIVAN)
has established itself as an important cause of kidney failure.
In fact, HIV-related kidney disease is now the third leading
cause of end-stage renal failure among African Americans
aged 20–64 in the United States,3 occurring almost exclusively
in this group and pointing towards a possible genetic influ-
ence. Histologically, the disease is characterized by a focal
segmental sclerosing glomerulopathy, with or without a
collapsing component and prominent tubulointerstitial
changes, including cystically dilated tubular profiles. Similar
histologic findings have been reported in association with
intravenous heroin use4 and in patients treated with bispho-
sphante pamidronate. It is now felt that HIVAN is caused by
direct viral infection of renal cells, particularly the visceral
epithelial cells of the glomerulus and the tubular epithelial
cells.
Besides HIVAN, it is known that a number of other renal
diseases occur in HIV-infected patients. A recent report
showed ‘non-HIVAN’ renal pathology is occurring in over
half (47) of the 89 biopsies.5 The etiological role of the virus
in these pathologies is not known. It has not been well docu-
mented to what extent ‘non-HIVAN’ pathologies affect Black
patients. Indeed, some authors consider these pathologies
to be more common in Caucasian patients.6,7
Although the vast majority of infected patients reside in
sub-Saharan Africa (roughly 75%), there is a paucity of
published data from this continent. This is particularly true
for HIV-related kidney disease. For this reason, we undertook
a retrospective biopsy review of our HIV-positive patients to
determine the prevalence of both HIVAN and ‘non-HIVAN’
renal pathologies in Africans and to study their clinical
presentations. We also wanted to compare our HIV-positive
patients with our HIV-negative patients to try to understand
the influence of the virus on the prevalent kidney disease
patterns in this group.
RESULTS
HIV-positive group
During the 2-year period, we obtained 104 biopsies from 104
HIV-positive patients. Five of these were considered inade-
quate to make a diagnosis. The remaining 99 biopsies were
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from Black African patients. Their clinical characteristics and
histologic patterns can be seen in Table 1. The majority were
young males. The mortality rate was high with 44 of the
patients dead at the end of the study period and 23 being lost
to follow-up.
A breakdown of the various histological categories can be
seen in the Figure 1.
We subdivided our patients according to their histological
patterns using the following guidelines:
Classic HIVAN. Twenty-seven patients (27%) were placed
in this category.
Biopsies showed focal segmental sclerosing glomerulo-
pathy, with or without an associated collapsing component.
Mesangial hyperplasia, with a variable increase in the
mesangial cellularity and/or mesangial matrix tissue deposi-
tion was usual. There was overlying visceral epithelial cell
prominence, often associated with hyaline droplet change
within Bowman’s space. The interstitium showed microcystic
change of the proximal convoluted tubular profiles, with
varying degrees of interstitial fibrosis, tubular atrophy, and
interstitial inflammation. The blood vessels were either
normal or showed segmental arteriolar hyalinosis with
fibro-elastic hyperplasia of the interlobular arteries. Immu-
nofluorescence microscopy was either negative or showed
nonspecific trapping of immunoglobulin (Ig)M with or
without complement component C3.
These patients tended to present with substantial protein-
uria (mean of 11.8 g/day), advanced renal failure (mean
creatinine 770 mmol/l), and low CD4 counts (mean 149).
However, there was a wide variation among the above
Table 1 | Clinical characteristics of all HIV-positive patients who were biopsied
Mean (s.d.) HIVAN ICD Membranous PIGN Mes prolif IgA Other GN’s Other
Number 27 21 13 8 6 5 9 10
Sex (females) 13 8 7 1 3 2 2 4
Age (years) 35 (9) 35 (9) 34 (8) 36 (8) 34 (11) 32 (10) 27 (6) 37 (9)
Bpsys 131 (30) 132 (30) 143 (34) 136 (33) 113 (16) 121 (29) 133 (17) 152 (50)
Bpdias 80 (17) 80 (19) 87 (23) 82 (27) 67 (7) 81 (17) 78 (8) 88 (44)
Serum creatinine (mmol/l)a 770 (506) 493 (387) 713 (707) 319 (478) 273 (214) 507 (529) 343 (468) 1317 (87)
CD4 counta 149 (182) 118 (85) 327 (269) 296 (117) 157 (156) 216 (192) 358 (193) 221 (132)
Proteinuria (g/day)b 11.8 (10.3 4.3 (5.4) 6.8 (5) 3.5 (1.7) 6.9 (6.6) 6 (6) 6.4 (5.5) 3.0 (1.0)
Serum albumin (g/dl)b 21 (9) 29 (8) 27 (9) 23 (6) 19 (9) 27 (8) 24 (9) 31 (4)
Serum cholesterol (mmol/l) 5.7 (2.8) 4.9 (2) 6.0 (2.4) 3.8 (0.8) 5.9 (2.4) 3.2 7.1 (3) 4.7 (1.9)
Hepatitis B surface antigenc 4 out of 23 1 out of 18 2 out of 12 1 out of 7 1 out of 4 0 out of 5 2 out of 7 0 out of 8
Hepatitis C antibodiesc 0 out of 23 0 out of 18 1 out of 12 0 out of 7 0 out of 4 0 out of 5 0 out of 7 0 out of 8
Anti nuclear factorc 0 out of 17 0 out of 13 1 out of 10 0 out of 4 1 out of 3 0 out of 3 2 out of 7 0 out of 4
Treatment: ACE inhibitors 16 17 12 4 4 2 7 6
Prednisone 4 2 4 0 2 0 3 0
Simvastatin 9 5 6 1 2 0 4 3
HAART 3 4 0 0 0 0 0 1
Follow-up (weeks) 17 (23) 14 (16) 24 (29) 28 (29) 22 (30) 17 (16.8) 24 (16) 23 (30)
Lost to follow-up 9 3 2 2 3 0 1 3
Alive 5 out of 18 9 out of 18 4 out of 11 3 out of 6 1 out of 3 1 out of 5 6 out of 8 3 out of 7
ACE, angiotensin-converting enzyme inhibitor; HAART, highly active antiretroviral therapy; HIVAN, HIV-associated nephropathy; ICD, immune complex disease; PIGN, post-
infectious glomerulonephritis; Mes prolif, immune complex-negative mesangial proliferation; IgA, IgA nephropathy; other GN’S, other glomerulonephritides; other, other renal
diseases.
P=0.006; bP=0.003; P-values only shown where o0.05.
cPositive results out of those whose relevant information was available (i.e. some data missing in records).
HIV-positive patients biopsied between 2003 and 2004
(99 pts.)
HIVICK, 21%
Other GN's, 9%
MP, 6%
Other, 10%
PIGN, 8%
Membranous, 13%
IgAN, 5%
HIVAN, 27%
HIV-negative patients biopsied between 2003 and 2004
(48 pts.)
FSGS, 17%
MCD, 17%
PIGN, 6%
Other GN's, 8%
IgAN, 4%
MP, 4%
Membranous, 19%
Other, 13% MPGN, 13%
Figure 1 | Comparing HIV-positive with HIV-negative patients biopsied during the study period. HIVICK: immune complex deposition
disease; other GN’s: other glomerulonephritides; HIVAN: collapsing nephropathy; IgAN: IgA nephropathy; PIGN: post-infectious
glomerulonephritis; other: other (non-glomerulonephritic) renal disease; MP: mesangial proliferative glomerulonephritis; FSGS: focal
glomerulosclerosis; and min change: minimal change.
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variables, with proteinuria ranging from 1.7 to 40 g/day,
creatinines from 39 to 1971 mmol/l, and CD4 counts from 1
to 651 cells/cm3.
In the absence of antiretrovirals or renal replacement
therapy, the majority was dead by the end of the study (13
out of the 18 who were not lost to follow-up).
Immune complex disease HIV immune complex kidney. Twenty-
one patients (21%) were placed in this category.
Glomerular changes were predominantly mesangial, ran-
ging from segmental to global with mild to moderate
hyperplasia. Varying numbers of immune deposits were
discernible on light microscopy within the mesangial and
paramesangial regions (see Figures 2 and 3).
Numerous biopsies also showed varying numbers of large
subepithelial deposits associated with a basement membrane
reaction and resulting in a ‘ball-in-cup’ architectural pattern
(see Figures 4 and 5). Scattered basement membrane holes
were visible. In some, marked crescent formation was
evident. We felt the above morphologic pattern did not fit
with any well-described classic immune-complex-mediated
glomerulonephritis, but had overlap features between
incompletely expressed ‘post-infectious’ and membranous
glomerulopathies.
Immunofluorescence microscopy confirmed the immune
deposits, with varying staining patterns for IgG, IgM, IgA,
and complement component C3. Several of the biopsies
showed a ‘full-house’ ‘lupus-like’ immunofluorescence pat-
tern.
The interstitium invariably had some degree of inflamma-
tion, fibrosis, and tubular atrophy. Furthermore, some of the
biopsies showed microcystic change of the tubular profiles.
The blood vessels were usually normal, but occasionally
had combined features of a thrombotic microangiopathic
process, with areas of transmural fibrinoid change, red cell
extravasation, intimal basophilic mucoid degeneration, and
endothelial cell swelling.
The clinical profile of patients with ‘HIV immune
complex kidney (HIVICK)’ was similar to those with ‘classic
HIVAN’, although the former tended to have less proteinuria
(4.3 vs 11.8 g/day) together with better creatinines (493 vs
770 mmol/l) and better albumins (29 vs 21 g/dl) on presenta-
tion. This was in spite of slightly worse CD4 counts (118 vs
149 cells/cm3). Of the 18 patients not lost to follow-up, nine
survived.
Membranous glomerulopathy. Thirteen patients (13%)
were grouped in this category.
Glomeruli showed thickening and rigidity of the peri-
pheral capillary walls and glomerular basement membranes.
Figure 2 | Global mesangial hyperplasia, with eosinophilic
deposits within the mesangial and paramesangial regions
(see encircled tuft). Silver–methenamine stain, original
magnification,  1000 (oil-immersion).
Figure 3 | Electron microscopy depicting electron-dense deposits
within the mesangial and paramesangial regions (see black
arrows).
Figure 4 | Subepithelial eosinophilic deposits in relation to the
glomerular basement membranes, with a ‘ball-in-cup’ reaction
pattern (see encircled and enlarged tuft with capillary loop).
Silver–methenamine stain, original magnification,  1000
(oil-immersion).
Figure 5 | Electron microscopy depicting a subepithelial
‘ball-in-cup’ deposit (see black arrow).
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Numerous subepithelial deposits were evident, inducing a
typical ‘spike and chain’ basement membrane reaction.
In addition to pure membranous-type changes, some
biopsies had features of ‘classic HIVAN’ with associated
microcystic change of the tubular profiles. These patients
were classified as having membranous nephropathy. Occa-
sional biopsies showed additional segmental sclerosing
glomerular lesions suggestive of ‘classic HIVAN’.
Clinically, patients tended to have heavy proteinuria with
marked renal impairment, although there was a wide range of
variation. Two patients were Hepatitis B positive. Seven out
of the 11 patients who were not lost to follow-up died.
‘Post-infectious’ diffuse proliferative glomerulonephritis. Eight
patients (8%) belonged to this group.
Biopsies displayed a diffuse proliferative glomerulone-
phritis, with endocapillary features and subepithelial ‘hump’-
type deposits.
These patients had marked renal impairment with marked
proteinuria, but less severe than those with ‘classic HIVAN’
or ‘HIVICK’.
Mesangial hyperplasia. Six patients (6%) had pure
mesangial changes consisting of an increase in cellularity
and matrix tissue deposition. The immunofluorescence
findings were negative. The interstitium showed varying
degrees of inflammation and fibrosis, with occasional cystic
dilatation of tubules.
This group had low CD4 counts (average 157 cells/cm3)
together with high creatinines (273 mmol/l) and heavy
proteinuria (6.9 g/day).
These patients were considered to represent the forme-
fruste of an evolving HIVAN, caught before the development
of segmental sclerosing lesions.
IgA nephropathy. The five patients (5%) in this group all
had mesangial hyperplasia with immunofluorescence micro-
scopy showing dominant IgA deposition.
These patients had low CD4 counts together with marked
renal dysfunction (creatinine 507 mmol/l) and heavy protein-
uria (6 g/day).
Other glomerulonephritides.
1. Three patients had ‘non-HIVAN’ focal segmental glomer-
ulosclerosis with hyalinosis (FSH). Although these patients
had focal segmental sclerosing glomerular lesions, they
were non-collapsing and there were no typical tubu-
lointerstitial changes of ‘classic HIVAN’.
2. Two patients had membranoproliferative glomerulo-
nephritis with ‘tram tracking’ of glomerular basement
membranes on silver staining and subendothelial im-
mune deposits. There was diffuse and global glomerular
hypercellularity, often accompanied by lobular accent-
uation of the glomerulus. Both were Hepatitis C
antibody negative
3. Two patients with minimal change disease had normal
histology on light microscopy and immunofluorescence.
4. One patient with lupus nephritis, WHO Type IV (diffuse
nephritis), was known to have lupus before biopsy.
5. One patient with chronic glomerulonephritis could not be
typified further because of diffuse global glomerulo-
sclerosis.
Other renal diseases.
1. Three patients had malignant hypertension with ischemic
glomeruli, collapsed peripheral capillary loops, and
wrinkled basement membranes. Arterioles showed hy-
perplasia with fibrinoid change. The arteries showed a
hyperplastic arteritis, with ‘onion-skin’ vessel wall
thickening. Accompanying high blood pressures led us
to favor a diagnosis of malignant hypertension over an
HIV-associated thrombotic microangiopathy. The inter-
stitium showed extensive fibrosis, with tubular atrophy.
2. Three patients had normal glomeruli but marked
tubulointerstitial nephritis, with features of both activity
and chronicity. No cystically dilated tubular profiles were
discernible.
3. Two patients had features of acute renal tubular necrosis
with normal glomeruli
4. Two patients showed the features of a diabetic nephro-
pathy. The diagnoses of diabetes were known before
biopsy.
HIV-negative group
The histologic diagnoses in this group can be seen in the
Figure 5.
The HIV-positive and HIV-negative groups were similar
in terms of age, gender, and racial make-up using the
Mann–Whitney U-test.
There were no examples of a collapsing ‘HIVAN’-like
nephropathy in the HIV-negative group. There was a high
prevalence (17%) of patients with features of an FSH/focal
glomerulosclerosis. This was not associated with the collap-
sing form of FSH, nor was there microcystic dilatation of the
tubular profiles, as can be seen with HIVAN. There were
statistically significant increased numbers of minimal change
disease (P¼ 0.0006) and membranoproliferative glomerulo-
nephritides (P¼ 0.0016) in the HIV-negative group.
There were no examples of immune-complex-mediated
glomerulopathies in that they did not fit a classic morpho-
logic reaction pattern.
With regards the other histologic subtypes (membranous,
‘post-infectious’, IgA nephropathy, and ‘other’ non-glomer-
ulonephritic lesions), there was no statistical difference
between the HIV-positive and HIV-negative groups.
DISCUSSION
Although HIVAN is thought to be the most common form
of chronic kidney disease in those of African descent who
are HIV positive, this entity accounts for only about half
of all renal pathology. HIVAN is most likely owing to direct
viral infiltration of renal cells,8–10 but the role of the virus in
non-HIVAN HIV-related nephropathy remains one of
conjecture.
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In our biopsy series of 99 in-hospital HIV-positive
patients, we have described a broad spectrum of histologic
patterns. Comparing our HIV-positive and HIV-negative
patients, we found a similar prevalence of many histologic
variants (excluding non-HIVAN focal glomerulosclerosis,
minimal change, and membranoproliferative glomerulo-
nephritis). The predominant pathologies in the HIV-positive
group, however, were ‘classic HIVAN’ and ‘HIVICK’. This
would tend to support a causative role for the virus in these
two pathologies, in our view.
‘Classic HIVAN’ accounted for less than a third of all
patients. They presented at any stage of HIV infection and
with varying degrees of renal disease in terms of glomerular
filtration rate and proteinuria, in agreement with other
authors.11–13 All the patients in our series with HIVAN
acquired their HIV infection in ways other than intravenous
drug use. This re-emphasizes that the route of transmission is
irrelevant to the pathogenesis of the condition.
Although there are limitations to drawing conclusions
from our retrospective review (single center study, single
pathologist not blinded to clinical data, small numbers), it
appears difficult predicting renal histology on the basis of
clinical criteria. Patients with HIVAN and HIVICK made up
the biggest proportion, but accounted for less than half the
group (48%). Although patients with HIVAN tended to have
heavier proteinuria, higher creatinines, and lower CD4
counts, there was marked overlap with the other groups.
There was no difference between the groups in terms of any
of the other clinical parameters. Thus, renal biopsy remains
the gold standard for diagnosing HIV-related nephropathies.
Following diagnosis, those with HIVAN tend to progress
to end-stage renal failure within months.14 This was certainly
our experience. Approximately 30 out of the 38 million HIV-
infected people worldwide reside in sub-Saharan Africa.15 If
other authors are correct16,17 and 3.5–12% of Black Africans
with HIV are at risk of developing HIVAN, it is clear that
Africa is facing an epidemic of renal failure (1–3.5 million
people) for which it is ill-equipped.
‘HIVICK’, thought by some to occur predominantly in
Caucasians, was commonplace in our series. Twenty-one
patients had this histologic pattern, second only to those with
‘classic HIVAN’ (27 patients). This group included patients
with a ‘lupus-like’ picture, in spite of being antinuclear factor
negative. Although it is not known whether HIV is the cause
of this nephropathy, it is known that immune dysregulation
can occur. In HIV-infected patients, there are often large
amounts of circulating antigen associated with a polyclonal
antibody response. This could lead to the formation of
immune complexes, either in the circulation or in situ in the
kidney itself. The concomitant activation of inflammatory
mediators would then result in secondary renal damage in a
manner analogous to lupus nephritis.
In the HIVICK group, the predominant histologic pattern
included variable mesangial alterations, with identifiable
immune deposits within the mesangial and paramesangial
regions. In addition, some of the biopsies showed a peculiar
and to our knowledge not previously described pattern, in
which a varying number of subepithelial immune deposits
were seen inducing a peculiar localized ‘ball-in-cup’ reaction
pattern from the basement membrane. These deposits are
reminiscent of the subepithelial ‘humps’ seen in a ‘post-
infectious’ diffuse proliferative glomerulonephritis while the
basement membrane reaction was similar to a membranous
glomerulonephritis. However, diffuse spike formations were
not evident, nor were there the numerous subepithelial
deposits of a membranous nephropathy. Thus, this picture
has overlap features between incompletely expressed ‘post-
infectious’ diffuse proliferative and membranous glomerulo-
nephritides. We propose this may be as a consequence of HIV
immune dysregulation. The deposits themselves may well
contain viral particles and stains for this may be informative
in future.
In addition, several of the ‘HIVICK’ patients had the
tubulointerstitial changes of ‘classic HIVAN’, in the absence
of focal segmental sclerosing glomerular lesions. This may
indicate that the microcystic tubulointerstitial changes occur
independently of the glomerular lesions. The typical micro-
cystic tubulointerstitial change may be a result of direct viral
infection of tubular epithelial cells, whereas the focal
segmental sclerosing glomerular lesions may be a result of a
visceral epithelial cell infection.
The next most common histological pattern was mem-
branous nephropathy. It is not clear that HIV is etiologically
implicated, although it is known that other infective agents
(including viruses) can cause the membranous pattern of
disease. However, there was a similar prevalence of
membranous nephropathy in our HIV-positive and HIV-
negative groups, so that the virus may be co-incidental.
There were a similar number of patients with ‘post-
infectious’ nephropathy in the HIV-positive and HIV-
negative groups so that it is difficult to draw any conclusions
as to the etiology of the virus in this histologic variant.
The group of six patients with immunofluorescence-
negative mesangial hyperplasia, as mentioned above, may
well represent classic HIVAN in an early stage of its evolution.
Repeat biopsies may well be informative in this group.
Although IgA nephropathy has been thought to be rare in
people of Black African origin, it certainly occurred in both
our HIV-negative and HIV-positive patients with equal
frequencies. This nephropathy has been described by several
authors in the context of HIV infection.18–21
Based on the fact that the other glomerulonephritides
occurred with equal frequencies in both the HIV-positive and
HIV-negative groups, we would argue that these diseases
were co-incidental to the infection, but this remains pure
conjecture.
Three patients had morphologic features of FSH, non-
collapsing subtype, with no typical tubulointerstitial changes
of classic HIVAN. These were interpreted as non-HIV-related
FSH, owing to the absence of microcystic tubular dilatation
and the absence of a ‘collapsing’ form of FSH. The high preva-
lence of the non-collapsing form of FSH in the HIV-negative
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group (17%) may indicate that this group of patients displays
susceptibility towards this form of renal scarring
regardless of the initiating insult. These patients were nephrotic
on clinical presentation and the HIV infection was associated
with near normal CD4 counts.
Of interest was the paucity of minimal change disease and
membranoproliferative glomerulonephritis in our HIV-
positive patients. The reasons for this are not clear, but
would seem to argue against an etiological role for the virus
in these nephropathies.
Our remaining patients with non-glomerulonephritic-
type renal disease had various pathologies ranging from
diabetic nephropathy to malignant hypertension, acute
tubular necrosis, and tubulointerstitial nephritis. As the
majority of our patients with glomerular pathology had
moderate to severe interstitial disease, it is very possible to
imagine an etiological role for the HIV virus in the pathology
of tubulointerstitial nephritis.
In conclusion, it is obvious that there is a wide range of
kidney diseases that can occur in the context of HIV-infected
individuals of African origin. Although ‘classic HIVAN’ may
well be the most common histologic pattern, a number of
other pathologies may be found. These may or may not be as
a result of viral infection. The immune complex disease
pattern of HIVICK was almost as common in our experience
and may well be a consequence of HIV infection.
It is apparent that many patterns of renal pathology occur
in HIV-infected patients. Thus, we would propose an
international, multi-center collaboration to try and establish
a classification system for HIV-related kidney disease.
Even though much is to be learnt about the etiology,
natural history, and treatment of the different types of HIV-
related nephropathy, the renal biopsy plays a pivotal role in
identifying the disease pattern present. In future, we would
hope to establish screening programs for those at risk of
developing HIV-related chronic kidney disease and then
evaluate therapies aimed at slowing the often rapid progres-
sion of these pathologies. Screening strategies would proba-
bly include routine serum creatinine and urinary protein or
even microabluminuric estimations in Black HIV-infected
patients.
One of the tragedies of HIV-related nephropathy is that
the bulk of these diseases occur in a region of the world that
is least able to cope at present. Optimal treatment regimens
remain largely unknown. Effective therapeutic measures will
need to be coupled with carefully thought out screening
strategies. It is imperative that properly conducted rando-
mized prospective trials be set up to evaluate these to try and
combat this important cause of kidney failure in the
developing world.
MATERIALS AND METHODS
Background
Chris Hani Baragwanath Hospital is a 2888-bed institution located
in Soweto on the outskirts of Johannesburg. It serves approximately
five million people, the majority of whom are Black Africans. Based
on antenatal clinic attendees, 29.4% of those living in Gauteng
province (where Soweto is located) are HIV positive.22 It is
estimated that 40–50% of all admissions to our Internal Medicine
Department, from where we get most of our referrals, are infected.
There are few outpatient referrals to our Nephrology practice
because of the rudimentary primary health-care infrastructure in the
area.
HIV-positive group
Our retrospective cohort included all patients with documented
HIV infection who underwent renal biopsy from 1st January 2003 to
31st December 2004. The indications for biopsy were left up to the
attending Nephrologist in each case. Permission for the review was
gained from the University of the Witwatersrand Ethics Committee.
All patients who were biopsied signed consent and had routine
blood tests performed before the procedure, including: serum
creatinine and urea, bleeding profile, viral serology (Hepatitis B
surface antigen, Hepatitis C antibodies, and HIV antibodies),
syphilis serology, streptococcal serology, antinuclear antibody, and
complement. Spot urine protein creatinine ratios were also
performed as routine. Results from all investigations were
documented where available. All biopsies were submitted for light
microscopy and immunofluorescence, but only for electron
microscopy where considered necessary by our pathologist. Biopsies
were studied by the same pathologist who was provided with a basic
clinical background, including the HIV status of the patient
concerned.
Biopsies insufficient to make a diagnosis were not included in the
study. Further data were gathered from patient records and
included: demographic details, blood results (as listed above),
CD4 counts where possible, presenting blood pressure, and use of
medications (angiotensin-converting enzyme inhibitors (perindo-
pril), statins (simvastatin), steroids, and antiretrovirals). Antiretro-
virals were supplied by our hospital from June 2004 onwards, so that
the minority of patients was on this therapy. Owing to financial
constraints, chronic dialysis was not made available to HIV-positive
patients in our hospital. Thus, end-stage renal failure inevitably
resulted in death for the patient concerned.
Follow-up duration was measured from the date of the biopsy
until the recorded date of death or, in the case of those who were lost
to follow-up, the date of the last documented clinic visit. Patients
were considered lost to follow-up if they did not arrive for scheduled
clinic appointments and could not be tracked using either phone
numbers or home visits, or their deaths were not recorded at the
Department of Home Affairs in Johannesburg, where all death
certificates are registered. For those who were known to still be alive,
duration was from the date of biopsy until the study closure date of
31st December 2004.
All patients were considered to be Black by the Nephrologists
involved. Although mode of HIV transmission was not recorded,
infection in Soweto is thought to be largely owing to heterosexual
sexual contact. Intravenous recreational drug abuse is considered to
be virtually non-existent.
HIV-negative group
To try make inferences about the etiological role of HIV infection
in certain forms of renal pathology, we compared the above-men-
tioned HIV-positive group with an HIV-negative ‘control’ group.
The latter was made up of all HIV-negative patients attending our
outpatient department who were biopsied during the same time
(2003–2004).
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Statistics
In the HIV-positive group, patients were categorized according to
their histological patterns. In the case of a histological pattern that
contained fewer than five examples, the patients were grouped
together as either ‘other glomerulonephritides’, or else, in the case of
non-glomerulonephritic disease, ‘other kidney disease’. Statistical
analysis was performed using the Statistica 6.0 software package
from Statsoft. Differences between the various groups were analyzed
using the non-parametric Kruskal–Wallis analysis of variance by
Ranks test.
The demographic make up of the HIV-positive and HIV-negative
groups were compared using the Mann–Whitney U-test. Once the
prevalence of varying histological diagnoses was known in the two
groups, they were compared using the Fisher exact two-tailed test to
try and asses any differences in the prevalence of renal pathology.
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